Treating Lung Disease in Patients Who Received New Drug for Advanced Cancer
Mount Sinai School of Medicine
Close monitoring and proactive management could reduce the risk of lung disease
Lungs
AI Performs as Well as Medical Specialists in Analyzing Lung Disease
Nagoya University
Researchers hope that specialists will use AI to ensure that they do not miss opportunities for early treatment
New Biomarker Speeds Identification of Lung Disease
Lawson Health Research Institute
Testing for a specific protein in biopsy tissue may help more accurately identify IPF
WHO Announces Updates on Its Guidance on Tuberculosis Care and Support
World Health Organization
New operational handbook on tuberculosis care has been launched
Predicting Immunotherapy Response for Lung Cancer
Mount Sinai Hospital
Biomarker in liquid biopsy could be more accurate than tumor biopsy at predicting therapy response
New Blood Test Can Help Doctors Diagnose Tuberculosis and Monitor Treatment
Tulane University
The CRISPR-based test uses a small blood sample and can deliver results within two hours
AI Helps Diagnose Post-COVID-19 Lung Problems
King Abdullah University of Science & Technology
New method overlays artificial intelligence algorithms on top of standard chest imaging data
New Tool Better Predicts COPD Risk for People of Non-European Ancestry
University of Virginia Health System
The more inclusive tool is better at predicting COPD risk in African-Americans than existing models
US Lung Cancer Screening Linked to Earlier Diagnosis and Better Survival
BMJ-British Medical Journal
Increases in the early detection of lung cancer since 2014 in the US have saved an estimated 10,100 lives
Real-World Increase in Biomarker Testing in Lung Cancer Patients
European Society for Medical Oncology
The overall survival of patients with lung cancer has also increased over the last decade